Metropolitan Life Insurance Company (MetLife)’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-48,386
| Closed | -$578K | – | 2070 |
|
|
2024
Q1 | $578K | Sell |
48,386
-446
| -0.9% | -$5.37K | 0.03% | 451 |
|
|
2023
Q4 | $529K | Sell |
48,832
-797
| -2% | -$7.63K | 0.02% | 455 |
|
|
2023
Q3 | $489K | Sell |
49,629
-2,622
| -5% | -$27.3K | 0.03% | 448 |
|
|
2023
Q2 | $521K | Sell |
52,251
-1,989
| -4% | -$19K | 0.03% | 449 |
|
|
2023
Q1 | $522K | Sell |
54,240
-15,900
| -23% | -$176K | 0.03% | 454 |
|
|
2022
Q4 | $781K | Sell |
70,140
-2,051
| -3% | -$21.4K | 0.03% | 416 |
|
|
2022
Q3 | $615K | Sell |
72,191
-829
| -1% | -$8.16K | 0.03% | 449 |
|
|
2022
Q2 | $765K | Sell |
73,020
-1,612
| -2% | -$17.7K | 0.03% | 435 |
|
|
2022
Q1 | $812K | Sell |
74,632
-63,586
| -46% | -$838K | 0.03% | 457 |
|
|
2021
Q4 | $1.87M | Sell |
138,218
-4,000
| -3% | -$53.4K | 0.03% | 570 |
|
|
2021
Q3 | $1.93M | Sell |
142,218
-4,762
| -3% | -$67.6K | 0.03% | 521 |
|
|
2021
Q2 | $2.1M | Sell |
146,980
-2,108
| -1% | -$30.5K | 0.03% | 496 |
|
|
2021
Q1 | $2.08M | Sell |
149,088
-7,280
| -5% | -$119K | 0.03% | 500 |
|
|
2020
Q4 | $2.93M | Buy |
156,368
+85,832
| +122% | +$1.4M | 0.04% | 346 |
|
|
2020
Q3 | $1.05M | Sell |
70,536
-3,117
| -4% | -$49.8K | 0.02% | 718 |
|
|
2020
Q2 | $1.18M | Sell |
73,653
-4,387
| -6% | -$71.1K | 0.02% | 634 |
|
|
2020
Q1 | $1.16M | Sell |
78,040
-298
| -0.4% | -$5.71K | 0.02% | 614 |
|
|
2019
Q4 | $1.57M | Buy |
78,338
+216
| +0.3% | +$4.02K | 0.03% | 669 |
|
|
2019
Q3 | $1.55M | Buy |
78,122
+333
| +0.4% | +$6.53K | 0.03% | 626 |
|
|
2019
Q2 | $1.48M | Buy |
77,789
+4,881
| +7% | +$108K | 0.03% | 669 |
|
|
2019
Q1 | $2.07M | Sell |
72,908
-1,950
| -3% | -$56.9K | 0.04% | 479 |
|
|
2018
Q4 | $2.05M | Sell |
74,858
-282
| -0.4% | -$9.14K | 0.04% | 407 |
|
|
2018
Q3 | $2.75M | Buy |
+75,140
| New | +$2.82M | 0.05% | 356 |
|
|
2015
Q1 | – | Sell |
-222,644
| Closed | -$12.6M | – | 2446 |
|
|
2014
Q4 | $12.6M | Sell |
222,644
-667
| -0.3% | -$35.8K | 0.09% | 232 |
|
|
2014
Q3 | $10.2M | Sell |
223,311
-3,438
| -2% | -$167K | 0.07% | 260 |
|
|
2014
Q2 | $11.7M | Sell |
226,749
-9,967
| -4% | -$490K | 0.08% | 243 |
|
|
2014
Q1 | $11.6M | Sell |
236,716
-9,943
| -4% | -$483K | 0.08% | 246 |
|
|
2013
Q4 | $10.7M | Sell |
246,659
-4,161
| -2% | -$171K | 0.08% | 255 |
|
|
2013
Q3 | $9.57M | Sell |
250,820
-1,582
| -0.6% | -$55.7K | 0.07% | 275 |
|
|
2013
Q2 | $7.83M | Buy |
+252,402
| New | +$7.54M | 0.06% | 324 |
|
Other funds holding VTRS
DSA
DM
Metropolitan Life Insurance Company (MetLife)'s VTRS Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Viatris (VTRS) in Q2 2024, closing a stake of 48,386 shares — an estimated $578K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in VTRS in Q2 2013 and held it in 30 quarters. The position peaked at $12.6M in Q4 2014. 996 funds tracked by Wall St. Rank hold VTRS as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Viatris position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 48,386 Viatris shares in Q2 2024, an estimated $578K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Viatris in Q2 2013 and held it in 30 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Viatris position peaked at $12.6M in Q4 2014.
- 996 funds tracked by Wall St. Rank held Viatris as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.